KM
NAMA / TGL
U
NO RM
MRS
DIAGNOSA
STATUS
LHR 2 November
SI
2015
A
WAN/ADH/EKP/JOE/KAP/HRE/ISH/SQB/LHB/RISKIE/SUHRI
TULIP (ISH,JOE)
PLAN
DPJP
Senin
Dl
m
8
tn. Winarno
8/8/45
7
0
0131826
4
29/1
0
BCC r. zigoma D
Ny. Marinem
15/12/62
5
2
0125296
8
28/1
0
Ca duct mamae S TxNxM1 paru
otak
0131319
7
28/1
0
Ca mame s T4cN2a M0 , post
kemo 1x brexel doxo
Op 30/10
PEMERIKSAAN PENUNJANG
BEDAH ONKOLOGI
Post Eksisi luas
WY
27/10 hb 13,9 al 6,6 at 163 pt 11 aptt 30, 30/10 gds 211 ot 17 pt 16 cr 1 ur 24 hbsag -
Perbaikan KU, konsul
bedah saraf, edukasi
keluarga
WY
28/10 hb 11 al 8,9 at 205
kemo
Perbaikna KU Hb> 10, pro
kemo
WY
1/11 hb 9.8 al 12.8 ht 31 at 349 28/10 ot 157 pt 113 cr 0,9 ur 70
rdtx
konsul radioterapi, paliatif
KY
18/10 hb 11,8 al 19 at 473 ot 95 pt 102 cr 0,8 ur 52 na 125 k 2,7 cl 75, 17/10/11 KD 11
2073 biopsi eksisi ca duct infiltratif, 21/10 sitologi pleura tdk ada sel2 ganas
M A W A R 1 (SQB, ADH)
6C
6J
6L
7E
7G
Ny. painem
Ny. Parni
19/5/54
6
1
0131737
9
18/1
0
Ca duct infiltratif mamae S
TxNxMx, riw kemo 6 x diklaten,
post MRM
Ny. Veri N
1/11/92
Ny.
Sumarmi
25/7/70
2
3
0124865
3
31/1
0
Ca mukoepidermoid
kemo
Pro kemo
DD
01/11 hb 10.1 at 30 al 7.3 at 194 29/10 gds 118 ot 13
4
5
0131780
1
28/1
0
SNNT S
Pre op
ismolobektomi
HK
20/10 hb 10,5 al 6,6 at 285 cr 0,5 ur 15 hbsag -, tsh 0,467 T3 1,11 T4 6,81,, usg nodul
tiroid s
Ny. Sukinem
26/9/70
4
4
0131248
4
29/1
0
Ca duct inv mamae STxN0M0 post
mastektomi, post kemo 6x riw
Op 31/10
tamofen 2th
Post Revisi MRM
KY
30/10 hb 13.1 al 8.3 at 283 pt 13 aptt 32.8 ot 20 pt 15, 22/10 JL 12 5878 PA ca duct inv
5
4
0119364
1
27/1
0
Adeno ca papiler tiroid
Post total tiroidektomi +
RND
HK
30/9 hb 12 al 7 at 270 18/9 DU 1510223 Biopsi coli metas adeno ca tiroid papiler
6
6
0131800
1
30/1
0
Tumor r.colli susp. Ca tiroid
Pro Total tiroidektomi
HK
30/10 hb 11 al 10 at 250 usg tiroid multiple nodul tiroid bilateral, multiple nodul
submandibula kiri, cea 3,49 ca 19-9 <3, TSH 0,36 ft3 4,68 ft4 12.4 , FNAB curiga ca kel.
tiroid
28/1
0
NHL large B cell ann arbor 4 post
kemo 1 10/10 haloxan 5000
mesna 5000 doxo 50
kemo
Pro kemo 2 haloxan 5000
mesna 5000 doxo 50
HK
5/10 hb 10,2 al 6,9 at 424ot 24 pt 10 cr 1,2 ur 45 hbsag -, 19/9/14 FNAB 1400694 NHL
large B cell, 3/2 usg abd massa paraaorta curiga limfoma hepatomegali,
Ca duct inf mamae D T4bN0M0
Op 30/10
Post MRM
HK
Invasive ca mamae d susp
maligna T3N1M0
Op 30/10
Post MRM
WY
Melanoma maligna r. pedis s
Pre op
Pro wide eksisi +
rekonstrksi
HK
Ca Lobularis mammae (D)
Pre op
Post MRM
DD
Op 27/10
Tunggu hasil PA, Konsul
BTKV utk wsd bila hasil ro
tho efusi pleura
HK
Rencana konferensi lagi
KY
Post Biopsi insisi dgn LA
WY
Ny. Yuliati
1/7/61
Melati 1 ( SQB)
7i
1H
3F
MA
1B
1D
2C
4C
4
9
Ny. Paliyem
19/8/49
tn.
3
0125642
Kustribowo
1
6
11/10/84
W A R 2 ( SOE, KAP, WAN)
Ny. Katinem
7
1318171
1/7/39
6
Ny. Parsi
4
0131670
2/6/70
5
4
Ny. Jamiyem
6
0131058
1/1/47
8
1
Ny. Sumarni
5
0130640
1/12/59
5
9
28/1
0
26/1
0
30/1
0
31/1
0
4D
Ny. Suyatmi
21/8/67
4
8
0130175
6
26/1
0
Tumor mamae d susp maligna
T4cN3 M1 paru post biopsi insisi
4I
Ny. Suyatmi
1/5/51
6
4
0127567
2
20/1
0
Adeno ca sternum dri tiroid
4H
Ny. Suratmi
22/3/77
2
8
0131857
5
28/1
0
Ca mamae d T4cN2CM1 paru
Op 29/10
Op 30/10
7B
tn. Ary S
23/9/76
3
9
0130963
3
24/1
0
Tumor lidah T4bN0M0
Op 27/10
7B
tn. Ary S
23/9/76
3
9
0130963
3
24/1
0
Tumor lidah T4bN0M0
Op 27/10
Tn. Supar
31/12/51
Melati 2 (KAP)
6
3
0131822
8
27/1
0
Adeno papiler tiroid
1
7
0131638
3
26/1
0
Abses parotis d
4
8
0130443
6
24/1
0
Ca duct inv mamae d T4bN2bM1
paru
6
0
0068242
6
28/1
0
Sccc r. inguinal, riw kemo brexel
50 carbo 300 5fu 5k erbitux 500
8E
7A
iskandar
Post Trakeostomi + biopsi
insisi, konsul gastro +
paru
Post Trakeostomi + biopsi
insisi, konsul gastro +
paru
MRI, total tiroidektomi Kp
RND
27/10 hb 12 al 5,9 at 267 pt 12 aptt 26 gds 446 ot 11 pt 9 cr 0,6 ur 26 hbsag -22/10 MF
112915 FNAB mamae D inf duct ca
271/0 hb 14 al 5,7 at 263 gds 430 , 15/10 hb 15 al 7 at 243 , 19/8 FNAB 1500639 inv ca
mamae D
31/10 7.0 ht 23 al 3.4 at 236 pt 13.3 aptt 27.4 INR 1020 ot 15 pt 13 ur 21 cr 0.6 albumin
3.3 na 142, k 3.1 cl 109 hbsag -,, 27/7 JI 52634 malignant melanoma
15/10 hb 12.8 ht 38 al 9.0 at 265 gds 115 ot 25 pt 17 ur 0.6 cr 12
27/10 ot 45 pt 8 ur 0.6 cr 26 na 138 k 5.0 cl 108 24/10 Hb 10,3 al 3,6 at 218 gds 108 ot
80 pt 22 cr 0,5 ur 14 hbsag -, 21/8 ro tho metas paru +, FNAB kesan metastases
adenokarcinoma
13/10 hb 12 al 8,6 at 208 gds 91 ot 18 pt 12 cr 0,8 ur 28 TSH <0,05 FT4 13,91, 6/8/14 DU
1410048 PA adeno ca , 27/10/14 ct torak soft tisue massa dinding dada anterior. MRI
Thorax : massa tiroid bilateral curiga malignan
28/10 hb 15 al 11 at 343 pt 17 aptt 42 gds 230 ot 26 pt 41 cr 0,7 ur 17 hbsag -, 8/10 FS
15 360 FNAB mamae + axila ca duct metas limfonodi axila
HK
24/10 hb 13 al 10 at 269 gds 90 ot 25 pt 17 cr 0,6 ur 16 na 129 k 2,4 hbsag -
HK
24/10 hb 13 al 10 at 269 gds 90 ot 25 pt 17 cr 0,6 ur 16 na 129 k 2,4 hbsag -
KY
27/10 hb 13 al 6,4 at 202 cr, 1,2 ur 29 hbsag -, 17/10 ptra medica adeno ca tiroid papiler
Antibiotik, fluktuasi -,
nyeri -
HK
24/10 hb 14 al 8,9 at 386 ot 18 pt 9 cr 0,8 ur 12
kemo
Kemo selese, kemo ke 5
mulai 29/10 brexel 80
platosin 60
HK
25/10 Hb 12 al 8,7 at 350, 18/9 Hb 9,4 al 7 at 652 gds 144 ot 28 pt 9 cr 0,6 ur 26, 19/6
RS 1502895 PA invasive ca mamae D
kemo
Post kemo brexel 50
carbo 300 5fu 5k erbitux
500 mulai 30/10
WY
5/10 RS 1504287 squamous cell ca berkeratin, 30/10 hb 10.8 ht 35 al 3.2 at 184 gds 88
ot 21 pt 32 cr 0,7 ur 41 , 2/10 RS 1504287 biopsi squamous cell ca berkeratin
Pre op
Mawar 3 (HRE, EKP)
2C
Ny. Supiyem
4/6/47
Melati 3 (HRE, EKP)
1A
Ny. Kusriyati
24/5/55
